or Try an Advanced Search...

    Non Small Cell Lung Cancer Stocks List

    Symbol Grade Name % Change
    XOMA A XOMA Corporation 0.60
    AVBP A ArriVent BioPharma, Inc. 4.91
    CNTA A Centessa Pharmaceuticals plc 4.19
    ACHV B Achieve Life Sciences, Inc. 0.64
    PYXS C Pyxis Oncology, Inc. 5.62
    BCAB C BioAtla, Inc. 8.85
    HCM C Hutchison China MediTech Limited 3.50
    PBYI C Puma Biotechnology Inc 3.51
    OPK C OPKO Health Inc. 0.00
    GNLX C Genelux Corporation -0.31
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Cancer Small Cell Lung Cancer Biopharmaceutical Solid Tumors Clinical Medicine Immunotherapy Medicine Prostate Cancer Antineoplastic Drugs Biotechnology Breast Cancer Cancer Treatment Clinical Trial Drugs Epidermal Growth Factor Receptor Gastric Cancer Immunology Immunotherapies Infectious Diseases Lung Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Non Small Cell Lung Cancer stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 3.06
    PBE C PowerShares Dynamic Biotech & Genome 2.56
    OZEM D Roundhill GLP-1 & Weight Loss ETF 1.35
    BBC B Virtus LifeSci Biotech Clinical Trials ETF 1.23
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 1.0
    View all Non Small Cell Lung Cancer ETFs...
    Compare ETFs
    Compare CNCR to OZEM Compare OZEM to LABD Compare PBE to LABD

        Non Small Cell Lung Cancer Stocks Recent News

        Date Stock Title
        Nov 1 OPK Waters (WAT) Beats Q3 Earnings and Revenue Estimates
        Oct 31 GNLX Genelux: H2 2025 PRROC Data Is A Major Inflection Point
        Oct 31 BCAB BioAtla to Announce Third Quarter 2024 Financial Results and Provide Business Highlights on November 7, 2024
        Oct 31 GNLX Individual investors who hold 56% of Genelux Corporation (NASDAQ:GNLX) gained 34%, institutions profited as well
        Oct 30 BCAB BioAtla, Inc. (NASDAQ:BCAB) has caught the attention of institutional investors who hold a sizeable 39% stake
        Oct 29 OPK OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024
        Oct 29 GNLX Genelux started at buy by Guggenheim ahead of Olvi-vec data
        Oct 28 PBYI 3 US Penny Stocks With Market Caps Under $700M
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Cancer Small Cell Lung Cancer Biopharmaceutical Solid Tumors Clinical Medicine Immunotherapy Medicine Prostate Cancer Antineoplastic Drugs Biotechnology Breast Cancer Cancer Treatment Clinical Trial Drugs Epidermal Growth Factor Receptor Gastric Cancer Immunology Immunotherapies Infectious Diseases Lung Cancer
        Non Small Cell Lung Cancer

        Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all cases. It is a type of cancer that begins in the cells that line the airways of the lungs. NSCLC is divided into three main subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Symptoms of NSCLC include a persistent cough, chest pain, shortness of breath, and coughing up blood. Treatment options for NSCLC include surgery, chemotherapy, radiation therapy, and targeted therapy.

        Browse All Tags